THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

Man Group plc's Holding History (CIK: 0001637460)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 117,084 Value ($000) $2,191 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 79,791 Value ($000) $1,165 Avg Close $12.64 Range $10.82 - $14.87

Q4 2024

Shares 10,328 Value ($000) $97 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 25,179 Value ($000) $203 Avg Close $8.66 Range $7.44 - $10.42

Q1 2024

Shares 10,101 Value ($000) $91 Avg Close $9.27 Range $8.21 - $11.71

Q4 2023

Shares 34,372 Value ($000) $386 Avg Close $10.06 Range $8.52 - $11.57

Q3 2018

Shares 8,942 Value ($000) $292 Avg Close $27.25 Range $22.26 - $32.79

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	117,084	$2,191	$16.59	$13.50 - $20.33
Q3 2025	79,791	$1,165	$12.64	$10.82 - $14.87
Q4 2024	10,328	$97	$9.10	$7.88 - $10.26
Q3 2024	25,179	$203	$8.66	$7.44 - $10.42
Q1 2024	10,101	$91	$9.27	$8.21 - $11.71
Q4 2023	34,372	$386	$10.06	$8.52 - $11.57
Q3 2018	8,942	$292	$27.25	$22.26 - $32.79